A detailed history of Clari Vest Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 2 shares of BIIB stock, worth $347. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$347
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$190.52 - $236.72 $381 - $473
2 New
2 $0
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $506 - $571
2 New
2 $0
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $1,551 - $2,055
-6 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$268.85 - $341.04 $268 - $341
1 Added 20.0%
6 $2,000
Q4 2019

Feb 12, 2020

SELL
$220.06 - $304.07 $189,691 - $262,108
-862 Reduced 99.42%
5 $2,000
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $188,520 - $211,443
867 New
867 $202,000
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $13 Million - $20.3 Million
-60,035 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$278.5 - $352.75 $743,873 - $942,195
-2,671 Reduced 4.26%
60,035 $18.1 Million
Q3 2018

Nov 07, 2018

SELL
$293.51 - $383.83 $1.26 Million - $1.65 Million
-4,308 Reduced 6.43%
62,706 $22.2 Million
Q2 2018

Aug 10, 2018

SELL
$257.52 - $306.91 $1.32 Million - $1.57 Million
-5,114 Reduced 7.09%
67,014 $19.5 Million
Q1 2018

May 08, 2018

SELL
$260.13 - $367.91 $498,929 - $705,651
-1,918 Reduced 2.59%
72,128 $19.7 Million
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $4.94 Million - $5.53 Million
16,046 Added 27.67%
74,046 $23.6 Million
Q3 2017

Nov 07, 2017

SELL
$281.15 - $329.69 $692,191 - $811,696
-2,462 Reduced 4.07%
58,000 $18.2 Million
Q2 2017

Nov 20, 2017

BUY
N/A
60,462
60,462 $16.4 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.